Research Summary
AI-generated summary of this SEC filing
Chemours (CC) Director Mary B. Cranston Buys 6,000 Shares
What Happened Mary B. Cranston, a director of Chemours Co. (CC), made an open-market purchase of 6,000 shares on August 7, 2026, at $15.82 per share for a total of $94,950. This was a straightforward purchase (transaction code P), which represents an insider buy rather than a sale.
Key Details
- Transaction date and price: 2026-08-07 — 6,000 shares at $15.82 each.
- Total transaction value: $94,950.
- Filing date: 2026-08-11 (the Form 4 was filed four days after the trade date; Form 4s are generally due within two business days, so this filing appears late).
- Shares owned after transaction: Not specified in the provided filing. Footnote F1 indicates reported ownership totals include directly owned shares, restricted stock units and dividend equivalent units.
- Footnotes: F1 — "Includes directly owned shares, restricted stock units and dividend equivalent units."
- No 10b5-1 plan, tax withholding, cashless exercise, gift, or other derivative details were disclosed in the provided information.
Context This was an open-market purchase by a non-employee director (not reported as a 10% owner), a type of insider activity many retail investors watch as a potential positive signal. The amount (~$95k) is modest relative to typical institutional moves; filings that are late should be noted but do not by themselves indicate misconduct. For full ownership details and any additional notes, review the original Form 4 filing (Accession No. 0001193125-26-344632).